| 注册
首页|期刊导航|中国当代儿科杂志|CCCG-ALL-2015方案治疗儿童急性淋巴细胞白血病复发的危险因素分析

CCCG-ALL-2015方案治疗儿童急性淋巴细胞白血病复发的危险因素分析

陈霞 雷小英 管贤敏 窦颖 温贤浩 郭玉霞 高惠琴 于洁

中国当代儿科杂志2024,Vol.26Issue(7):701-707,7.
中国当代儿科杂志2024,Vol.26Issue(7):701-707,7.DOI:10.7499/j.issn.1008-8830.2401010

CCCG-ALL-2015方案治疗儿童急性淋巴细胞白血病复发的危险因素分析

Risk factors for recurrence of childhood acute lymphoblastic leukemia after treatment with the Chinese Children's Cancer Group ALL-2015 protocol

陈霞 1雷小英 1管贤敏 1窦颖 1温贤浩 1郭玉霞 1高惠琴 1于洁1

作者信息

  • 1. 重庆医科大学附属儿童医院儿童血液肿瘤科/国家儿童健康与疾病临床医学研究中心/儿童发育疾病教育部重点实验室/儿科学重庆市重点实验室,重庆 400014
  • 折叠

摘要

Abstract

Objective To investigate the cumulative incidence of recurrence(CIR)in children with acute lymphoblastic leukemia(ALL)after treatment with the Chinese Children's Cancer Group ALL-2015(CCCG-ALL-2015)protocol and the risk factors for recurrence.Methods A retrospective analysis was conducted on the clinical data of 852 children who were treated with the CCCG-ALL-2015 protocol from January 2015 to December 2019.CIR was calculated,and the risk factors for the recurrence of B-lineage acute lymphoblastic leukemia(B-ALL)were analyzed.Results Among the 852 children with ALL,146(17.1%)experienced recurrence,with an 8-year CIR of 19.8%±1.6%.There was no significant difference in 8-year CIR between the B-ALL group and the acute T lymphocyte leukemia group(P>0.05).For the 146 children with recurrence,recurrence was mainly observed in the very early stage(n=62,42.5%)and the early stage(n=46,31.5%),and there were 42 children with bone marrow recurrence alone(28.8%)in the very early stage and 27 children with bone marrow recurrence alone(18.5%)in the early stage.The Cox proportional-hazards regression model analysis showed that positive MLLr fusion gene(HR=4.177,95%CI:2.086-8.364,P<0.001)and minimal residual disease≥0.01%on day 46(HR=2.013,95%CI:1.163-3.483,P=0.012)were independent risk factors for recurrence in children with B-ALL after treatment with the CCCG-ALL-2015 protocol.Conclusions There is still a relatively high recurrence rate in children with ALL after treatment with the CCCG-ALL-2015 protocol,mainly bone marrow recurrence alone in the very early stage and the early stage,and minimal residual disease≥0.01%on day 46 and positive MLLr fusion gene are closely associated with the recurrence of B-ALL.

关键词

急性淋巴细胞白血病/中国儿童肿瘤协作组急性淋巴细胞白血病2015方案/复发/危险因素/儿童

Key words

Acute lymphoblastic leukemia/Chinese Children's Cancer Group ALL-2015 protocol/Recurrence/Risk factor/Child

引用本文复制引用

陈霞,雷小英,管贤敏,窦颖,温贤浩,郭玉霞,高惠琴,于洁..CCCG-ALL-2015方案治疗儿童急性淋巴细胞白血病复发的危险因素分析[J].中国当代儿科杂志,2024,26(7):701-707,7.

中国当代儿科杂志

OA北大核心CSTPCDMEDLINE

1008-8830

访问量0
|
下载量0
段落导航相关论文